Skip to content
value.today

Carbylan Biosurgery, Inc

Total raised
$15 M
3 rounds on record
Latest round
$4 M
Feb 2015
First round on record
Dec 2012
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Carbylan Biosurgery, Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2015$4 MNo. 3$2 to $10 million

Carbylan Biosurgery, Inc: Raise no. 3, Feb 2015

Investors in this round

4 investors had bought by the notice of Mar 5, 2015: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Carbylan Biosurgery, Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David M. Gravett · Executive Officer
  • David M. Renzi · Executive Officer, Director
  • Hayley M. Lewis · Executive Officer
  • Marcee M. Maroney · Executive Officer
  • T. Michael White · Executive Officer
  • Albert L. Cha · Director
  • David W. Clapper · Director
  • Edward W. Unkart · Director
  • Guy P. Nohra · Director
  • Keith A. Katkin · Director
  • Reza P. Zadno · Director
  • Steven L. Basta · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Saul, Secretary. Source: SEC Form D, newest notice filed Mar 5, 2015. Read the notice at the SEC.

debt, optionsSEC
Sep 2014$5 MNo. 2$2 to $10 million

Carbylan Biosurgery, Inc: Raise no. 2, Sep 2014

Investors in this round

4 investors had bought by the notice of Oct 14, 2014: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Carbylan Biosurgery, Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David M. Gravett · Executive Officer
  • David M. Renzi · Executive Officer, Director
  • Hayley M. Lewis · Executive Officer
  • Marcee M. Maroney · Executive Officer
  • T. Michael White · Executive Officer
  • Timothy L. Trapp · Executive Officer
  • Albert L. Cha · Director
  • Guy P. Nohra · Director
  • Reza P. Zadno · Director
  • Steven L. Basta · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Saul, Secretary. Source: SEC Form D, newest notice filed Oct 14, 2014. Read the notice at the SEC.

debt, optionsSEC
Dec 2012$6 MNo. 1$2 to $10 million

Carbylan Biosurgery, Inc: Raise no. 1, Dec 2012

Investors in this round

4 investors had bought by the notice of Jan 3, 2013: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 7 investors are named for Carbylan Biosurgery, Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$6 M of $13 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Gravett · Executive Officer
  • George Daniloff · Executive Officer, Director
  • Marcee Maroney · Executive Officer
  • Mark Weeks · Executive Officer
  • Roxanne Dubois · Executive Officer
  • Albert Cha · Director
  • Chris Ehrlich · Director
  • Guy Nohra · Director
  • Steven Basta · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Weeks, Secretary. Source: SEC Form D, newest notice filed Jan 3, 2013. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Carbylan Biosurgery, Inc chose not to state its revenue in its newest notice of a funding round (Mar 2015).

    SEC Form D · Mar 2015

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Mar 2015

That is all the official record says: Carbylan Biosurgery, Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

7 named in official filings. Open an investor to see everything it has backed.

Investors in Carbylan Biosurgery, Inc
InvestorKindAmountRoundRoleSource
Acmp IV LLCOthernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Acp IV, L.P.Fund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
InterWest Management Partners IX, LLCFund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
InterWest Partners IX, LPFund or asset managernot statednot statedHeld Series A and B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Vivo Ventures Fund VI, L.P.Venture capitalnot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Vivo Ventures VI Affiilates Fund, L.P.Venture capitalnot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3
Vivo Ventures VI, LLCVenture capitalnot statednot statedHeld Series B preferred stock, 10% owner (Form 3, 2015)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 4 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Carbylan Biosurgery, Inc
NameRoleNamed in
David M. GravettExecutive officerMar 2015
David M. RenziExecutive officerMar 2015
Hayley M. LewisExecutive officerMar 2015
Marcee M. MaroneyExecutive officerMar 2015
T. Michael WhiteExecutive officerMar 2015
Timothy L. TrappExecutive officerOct 2014
David GravettExecutive officerJan 2013
George DaniloffExecutive officerJan 2013
Marcee MaroneyExecutive officerJan 2013
Mark WeeksExecutive officerJan 2013
Roxanne DuboisExecutive officerJan 2013
Albert L. ChaDirectorMar 2015
David M. RenziDirectorMar 2015
David W. ClapperDirectorMar 2015
Edward W. UnkartDirectorMar 2015
Guy P. NohraDirectorMar 2015
Keith A. KatkinDirectorMar 2015
Reza P. ZadnoDirectorMar 2015
Steven L. BastaDirectorMar 2015
Albert ChaDirectorJan 2013
Chris EhrlichDirectorJan 2013
George DaniloffDirectorJan 2013
Guy NohraDirectorJan 2013
Steven BastaDirectorJan 2013